| Swarmer Reports First Quarter Financial Results |
Globe Newswire |
05/13 |
08:00 |
| SoFi Announces Monthly Distributions on $THTA (10.00%) |
Globe Newswire |
05/13 |
08:00 |
| NOVAGOLD Releases 2025 Sustainability Report |
Globe Newswire |
05/13 |
08:00 |
| Cerence AI to Participate in TD Cowen 54th Annual Technology, Media & Telecom Conference |
Globe Newswire |
05/13 |
08:00 |
| Pacira BioSciences to Participate in Fireside Chats at Three Upcoming Healthcare Conferences |
Globe Newswire |
05/13 |
08:00 |
| Foremost Clean Energy Announces Expansion of the Tuning Fork Uranium Zone at Hatchet Lake South |
Globe Newswire |
05/13 |
08:00 |
| Allegro MicroSystems to Present at TD Cowen’s 54th Annual Technology, Media & Telecom Conference on Wednesday, May 27, 2026 |
Globe Newswire |
05/13 |
08:00 |
| ZUSDURI Median Duration of Response Still Not Reached with 64.5% 36-month Duration of Response in the Pivotal ENVISION Trial |
Globe Newswire |
05/13 |
08:00 |
| Moleculin Announces Imminent MIRACLE Trial Unblinding as Blinded Data Continue to Significantly Outperform Historical Benchmarks |
Globe Newswire |
05/13 |
08:00 |
| InnoCare Announce First Subject Dosed in Phase 1 Clinical Trial of ICP-054, a Novel Potentially Best-in-Class Oral IL-17AA/AF Inhibitor |
Globe Newswire |
05/13 |
07:43 |
| Nexxen Reports Record First Quarter 2026 Financial Results |
Globe Newswire |
05/13 |
07:30 |
| BriaCell Adds Penn Medicine’s Abramson Cancer Center as Clinical Site in Pivotal Phase 3 Breast Cancer Study |
Globe Newswire |
05/13 |
07:30 |
| MediPharm Labs Reports First Quarter 2026 Results Achieving Positive Adjusted EBITDA |
Globe Newswire |
05/13 |
07:30 |
| Hengrui Pharma and Kailera Therapeutics Announce Clinical Data Presentations at the American Diabetes Association 86th Scientific Sessions |
Globe Newswire |
05/13 |
07:30 |
| Abeona Therapeutics® Reports First Quarter 2026 Results and Provides Pipeline Update |
Globe Newswire |
05/13 |
07:30 |
| BrainsWay Reports First Quarter 2026 Financial Results and Operational Highlights |
Globe Newswire |
05/13 |
07:30 |
| Altimmune Announces First Quarter 2026 Financial Results and Business Update |
Globe Newswire |
05/13 |
07:30 |
| Dyne Therapeutics to Participate in Upcoming Investor Conferences |
Globe Newswire |
05/13 |
07:30 |
| Pyxis Oncology to Participate in Upcoming Investor Conferences |
Globe Newswire |
05/13 |
07:30 |
| PolyPid Provides Corporate Update and Reports First Quarter 2026 Financial Results |
Globe Newswire |
05/13 |
07:30 |
| Arbutus Reports First Quarter 2026 Financial Results and Provides Corporate Update |
Globe Newswire |
05/13 |
07:30 |
| Vishay Intertechnology Reports First Quarter 2026 Results |
Globe Newswire |
05/13 |
07:15 |
| Altimmune to Present Results of Pemvidutide in MASH in an Oral Presentation and Multiple Poster Presentations at EASL Congress 2026 |
Globe Newswire |
05/13 |
07:15 |
| Milestone Pharmaceuticals Announces First Quarter 2026 Financial Results and Provides Corporate Update |
Globe Newswire |
05/13 |
07:11 |
| Gilat Reports First Quarter 2026 Results |
Globe Newswire |
05/13 |
07:09 |
